Contacts
About the collection
PersisGene Accelerator started in 2016 with the investment of the private sector and the support of the Vice‑Presidency for Science and Technology as the accelerator of the country’s medical biotechnology.
The area of activity of this accelerator includes pharmaceutical and medical biotechnology, plasma-derived products, therapeutic serums, human and animal vaccines, herbal medicines, medicines of natural origin, and modern medicine (stem cells).
